M&A Deal Summary

Grünenthal Acquires Nebido

On July 14, 2022, Grünenthal acquired life science company Nebido from Bayer for 500M EUR

Acquisition Highlights
  • This is Grünenthal’s 5th transaction in the Life Science sector.
  • This is Grünenthal’s 0th largest (disclosed) transaction.
  • This is Grünenthal’s 2nd transaction in Germany.

M&A Deal Summary

Date 2022-07-14
Target Nebido
Sector Life Science
Buyer(s) Grünenthal
Sellers(s) Bayer
Deal Type Divestiture
Deal Value 500M EUR

Target

Nebido

Leverkusen, Germany
website
Nebido provides treatment of male hypogonadism (testosterone deficiency) is based in Leverkusen, Germany.

Search 191,543 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Grünenthal

Aachen, Germany

website


Category Company
Sector Life Science
DESCRIPTION

Grünenthal GmbH is an independent, family-owned, international research-based pharmaceutical company.


DEAL STATS #
Overall 7 of 7
Sector (Life Science) 5 of 5
Type (Divestiture) 2 of 2
Country (Germany) 2 of 2
Year (2022) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-12 Mestex AG

Basel, Switzerland

Mestex is a cluster for innovative pharmaceutical industries and biotech companies in Europe. The company with its brand Lopain provides solutions to all patients suffering from osteoarthritis-related joint pain. Mestex is based in Basel, Switzerland.

Buy -

Seller(S) 1

SELLER

Bayer

Leverkusen, Germany

website


Category Company
Founded 1863
Sector Life Science
Employees99,349
Revenue 50.7B EUR (2022)
DESCRIPTION
Bayer office building in North Sydney, Australia.
Bayer office building in North Sydney, Australia.

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer was founded in 1863 and is based in Leverkusen, Germany.


DEAL STATS #
Overall 20 of 21
Sector (Life Science) 5 of 5
Type (Divestiture) 16 of 17
Country (Germany) 11 of 12
Year (2022) 2 of 2
Size (of disclosed) 7 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-10 Bayer Environmental Science Professional

Cary, North Carolina, United States

Bayer Environmental Science Professional (BESP) is a global provider of products and services to create healthier environments, to manage pests, and to eliminate vector-borne diseases, across a range of end-markets. BESP has an extensive product portfolio to manage pests (such as rodents, pest insects and invasive weeds) in a sustainable and responsible manner, including for the vegetation management, range and pasture, forestry and turf and ornamentals markets. In addition, the business markets products to protect against vector-borne diseases such as malaria, and to promote public health objectives in the developing world. Bayer Environmental Science Professional is headquartered in Cary, North Carolina.

Sell $2.6B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-18 Blackford Analysis

Edinburgh, United Kingdom

Blackford Analysis provides infrastructure and access to a rich clinical application (ClinApp) ecosystem focused on imaging and analytics. Blackford Analysis is based in Edinburgh, United Kingdom.

Buy -